Modelling Parkinson's Disease: iPSCs towards Better Understanding of Human Pathology

被引:18
作者
Avazzadeh, Sahar [1 ]
Baena, Jara Maria [1 ]
Keighron, Cameron [1 ]
Feller-Sanchez, Yajaira [1 ]
Quinlan, Leo R. [1 ]
机构
[1] Natl Univ Ireland NUI, Sch Med, Physiol & CURAM SFI Ctr Res Med Devices, Galway H91 TK33, Ireland
关键词
Parkinson's disease; induced pluripotent stem cells; human pathology;
D O I
10.3390/brainsci11030373
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's Disease (PD) is a chronic neurodegenerative disorder characterized by motor and non-motor symptoms, among which are bradykinesia, rigidity, tremor as well as mental symptoms such as dementia. The underlying cause of Parkinson disease is degeneration of dopaminergic neurons. It has been challenging to develop an efficient animal model to accurately represent the complex phenotypes found with PD. However, it has become possible to recapitulate the myriad of phenotypes underlying the PD pathology by using human induced pluripotent stem cell (iPSC) technology. Patient-specific iPSC-derived dopaminergic neurons are available and present an opportunity to study many aspects of the PD phenotypes in a dish. In this review, we report the available data on iPSC-derived neurons derived from PD patients with identified gene mutations. Specifically, we will report on the key phenotypes of the generated iPSC-derived neurons from PD patients with different genetic background. Furthermore, we discuss the relationship these cellular phenotypes have to PD pathology and future challenges and prospects for iPSC modelling and understanding of the pathogenesis of PD.
引用
收藏
页数:26
相关论文
共 195 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism [J].
Aflaki, Elma ;
Borger, Daniel K. ;
Moaven, Nima ;
Stubblefield, Barbara K. ;
Rogers, Steven A. ;
Patnaik, Samarjit ;
Schoenen, Frank J. ;
Westbroek, Wendy ;
Zheng, Wei ;
Sullivan, Patricia ;
Fujiwara, Hideji ;
Sidhu, Rohini ;
Khaliq, Zayd M. ;
Lopez, Grisel J. ;
Goldstein, David S. ;
Ory, Daniel S. ;
Marugan, Juan ;
Sidransky, Ellen .
JOURNAL OF NEUROSCIENCE, 2016, 36 (28) :7441-7452
[3]   Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons [J].
Ahfeldt, Tim ;
Ordureau, Alban ;
Bell, Christina ;
Sarrafha, Lily ;
Sun, Chicheng ;
Piccinotti, Silvia ;
Grass, Tobias ;
Parfitt, Gustavo M. ;
Paulo, Joao A. ;
Yanagawa, Fumiki ;
Uozumi, Takayuki ;
Kiyota, Yasujiro ;
Harper, J. Wade ;
Rubin, Lee L. .
STEM CELL REPORTS, 2020, 14 (01) :75-90
[4]   The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease [J].
Albanese, A ;
Valente, EM ;
Romito, LM ;
Bellacchio, E ;
Elia, AE ;
Dallapiccola, B .
NEUROLOGY, 2005, 64 (11) :1958-1960
[5]   LRRK2 kinase in Parkinson's disease [J].
Alessi, Dario R. ;
Sammler, Esther .
SCIENCE, 2018, 360 (6384) :36-37
[6]   Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers [J].
Anheim, M. ;
Elbaz, A. ;
Lesage, S. ;
Durr, A. ;
Condroyer, C. ;
Viallet, F. ;
Pollak, P. ;
Bonaiti, B. ;
Bonaiti-Pellie, C. ;
Brice, A. .
NEUROLOGY, 2012, 78 (06) :417-420
[7]   PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease [J].
Arena, Giuseppe ;
Valente, Enza Maria .
JOURNAL OF PATHOLOGY, 2017, 241 (02) :251-263
[8]   FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling [J].
Arias-Fuenzalida, Jonathan ;
Jarazo, Javier ;
Qing, Xiaobing ;
Walter, Jonas ;
Gomez-Giro, Gemma ;
Nickels, Sarah Louise ;
Zaehres, Holm ;
Schoeler, Hans Robert ;
Schwamborn, Jens Christian .
STEM CELL REPORTS, 2017, 9 (05) :1423-1431
[9]   New insights on the mitochondrial proteome plasticity in Parkinson's disease [J].
Aroso, Miguel ;
Ferreira, Rita ;
Freitas, Ana ;
Vitorino, Rui ;
Gomez-Lazaro, Maria .
PROTEOMICS CLINICAL APPLICATIONS, 2016, 10 (04) :416-429
[10]   LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1 [J].
Azkona, Garikoitz ;
Lopez de Maturana, Rakel ;
del Rio, Patricia ;
Sousa, Amaya ;
Vazquez, Nerea ;
Zubiarrain, Amaia ;
Jimenez-Blasco, Daniel ;
Bolaos, Juan P. ;
Morales, Blas ;
Auburger, Georg ;
Matias Arbelo, Jose ;
Sanchez-Pernaute, Rosario .
MOLECULAR NEUROBIOLOGY, 2018, 55 (01) :506-516